Related Experiment Video
Updated: Jan 25, 2026

Generation of Subcutaneous and Intrahepatic Human Hepatocellular Carcinoma Xenografts in Immunodeficient Mice
Published on: September 25, 2013
Visualizing Engrafted Human Cancer and Therapy Responses in Immunodeficient Zebrafish
Chuan Yan1, Dalton C Brunson2, Qin Tang2
1Molecular Pathology Unit, Massachusetts General Hospital Research Institute, Charlestown, MA 02129, USA; Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, MA 02129, USA; Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA 02114, USA; Harvard Stem Cell Institute, Cambridge, MA 02139, USA.
We developed an optically-clear zebrafish model for dynamic, single-cell visualization of human cancer xenografts. This model revealed combination therapy efficacy for rhabdomyosarcoma by tracking cell cycle arrest and apoptosis.
Area of Science:
- Comparative immunology
- Cancer biology
- Zebrafish models
Background:
- Xenograft models are crucial for cancer drug preclinical efficacy assessment.
- Direct single-cell phenotype visualization in xenografts remains challenging.
Purpose of the Study:
- To develop an optically-clear zebrafish xenograft model for dynamic single-cell visualization of human cancers.
- To assess preclinical efficacy of combination therapy for rhabdomyosarcoma.
Main Methods:
- Utilized prkdc-/-; il2rga-/- zebrafish lacking adaptive and NK immune cells for xenotransplantation.
- Employed photoconversion cell-lineage tracing and FUCCI cell-cycle reporters for dynamic imaging.
- Administered combination olaparib (PARP inhibitor) and temozolomide (DNA-damaging agent) therapy.
Main Results:
- Successfully engrafted diverse human cancers in zebrafish at 37°C, enabling single-cell visualization.
- Identified migratory and proliferative cell states in human rhabdomyosarcoma.
- Demonstrated combination therapy arrested rhabdomyosarcoma cells in G2 phase, preceding apoptosis.
- Showcased successful engraftment of patient-derived xenografts.
Conclusions:
- The developed zebrafish model offers dynamic, single-cell resolution for cancer xenografts.
- Combination olaparib and temozolomide shows preclinical efficacy against rhabdomyosarcoma.
- This model facilitates personalized therapeutic development for various cancers.
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Gene Therapy
Group Therapy
Psychodynamic Therapy

